Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chantry

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Opinion on Emerging Drugs|May 25, 2004
HIV entry and fusion inhibitorsDavid Chantry
Expert Opinion on Emerging Drugs|November 13, 2003
G protein-coupled receptors: from ligand identification to drug targets. 14-16 October 2002, San Diego, CA, USADavid Chantry
Expert Opinion on Emerging Drugs|March 11, 2005
Inflammation Research Association: 12th international conferenceDavid Chantry, Laurence E Burgess
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Chemokines in allergyDavid Chantry, Laurence E Burgess
The Journal of Clinical Investigation|December 5, 2002
CCR4-bearing T cells participate in autoimmune diabetesSoon H Kim, Mary M Cleary, Howard S Fox, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonistsShelley Allen, Bradley Newhouse, Aaron S Anderson, et al.
The Journal of Experimental Medicine|September 18, 2002
A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activationElizabeth Clayton, Giuseppe Bardi, Sarah E Bell, et al.
The Journal of Allergy and Clinical Immunology|July 12, 2002
Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitisTakao Fujisawa, Ryuichi Fujisawa, Yoshiko Kato, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonistsBradley Newhouse, Shelley Allen, Benjamin Fauber, et al.
International Immunology|July 4, 2002
IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitisTatsuya Horikawa, Takashi Nakayama, Ichiro Hikita, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Emerging Drugs|May 25, 2004
HIV entry and fusion inhibitorsDavid Chantry
Expert Opinion on Emerging Drugs|November 13, 2003
G protein-coupled receptors: from ligand identification to drug targets. 14-16 October 2002, San Diego, CA, USADavid Chantry
Expert Opinion on Emerging Drugs|March 11, 2005
Inflammation Research Association: 12th international conferenceDavid Chantry, Laurence E Burgess
Current Drug Targets. Inflammation and Allergy|October 17, 2003
Chemokines in allergyDavid Chantry, Laurence E Burgess
The Journal of Clinical Investigation|December 5, 2002
CCR4-bearing T cells participate in autoimmune diabetesSoon H Kim, Mary M Cleary, Howard S Fox, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonistsShelley Allen, Bradley Newhouse, Aaron S Anderson, et al.
The Journal of Experimental Medicine|September 18, 2002
A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activationElizabeth Clayton, Giuseppe Bardi, Sarah E Bell, et al.
The Journal of Allergy and Clinical Immunology|July 12, 2002
Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitisTakao Fujisawa, Ryuichi Fujisawa, Yoshiko Kato, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonistsBradley Newhouse, Shelley Allen, Benjamin Fauber, et al.
International Immunology|July 4, 2002
IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitisTatsuya Horikawa, Takashi Nakayama, Ichiro Hikita, et al.
Pageof 2